NKENike, Inc.

$34.73-51% 1Y

Is the business good?

Mixed

The checks split: 5 of 9 health tests passed and returns not propped up by debt.

2 neutral, 2 without data
Fundamental health (F-score)5 / 9SEC EDGAR · May 31, 2026

Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.

Where ROE comes from7% ROAderived

A balanced mix of margins, efficiency, and leverage. ROE 19% = margin × turnover × leverage.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversionbehind 76% of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is NKE?

Nike, Inc. keeps 6.7% of every revenue dollar as profit after everything, against 5.7% for the median Footwear & Accessories name.

6.7%

Net margin · Footwear & Accessories median 5.7% · 12 months to Q1 2027

Share count, year on year
+0.35%

Share count, year on year · flat: no meaningful dilution

Gross margin
43%

Gross margin

Details›
Gross margin12 months to Q1 2027
43%
Net margin12 months to Q1 2027
6.7%
Free cash flow margin
4.6%
Revenue, trailing twelve months
$45.9B
Free cash flow, trailing twelve months
$2.10B
Net income, trailing twelve months
$3.09B

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.